Pharmacologic evidence for the presence of three functional endothelin receptor subtypes in rabbit saphenous vein

Journal of Cardiovascular Pharmacology

Volumn 26, Issue , 1995, Pages S163-S168

  Douglas, Stephen A ^a   Beck, George R ^a   Elliott, John D ^a   Ohlstein, Eliot H ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Bosentan RES 701; BQ 123; BQ 788; Endothelin receptors; ETB1 like receptor; ETB2 like receptor; ETc like receptor; PD 142893; Ro 462005; Saphenous vein SB 209670

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; 4 TERT BUTYL N [6 (2 HYDROXYETHOXY) 5 (3 METHOXYPHENOXY) 4 PYRIMIDINYL]BENZENESULFONAMIDE; BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR AGONIST; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N ACETYL 3,3 DIPHENYL DEXTRO ALANYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN; RECEPTOR SUBTYPE; RES 701 1; SARAFOTOXIN S6C; UNCLASSIFIED DRUG;

ANIMAL TISSUE; BINDING AFFINITY; BINDING SITE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG POTENCY; ENDOTHELIN C RECEPTOR; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR BINDING; SAPHENOUS VEIN; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

ANIMAL; ENDOTHELINS; ENDOTHELIUM, VASCULAR; IN VITRO; MALE; RABBITS; RECEPTORS, ENDOTHELIN; SAPHENOUS VEIN; VASOCONSTRICTION;

EID: 0028827684     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-199506263-00051     Document Type: Article

References (10)

1. Masaki T, Vane JR, Vanhoutte PM. V International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol Rev 1994;46:137-42.
2. Warner TD, Allcock GH, Corder R, Vane JR. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Br J Pharmacol 1993;110:777-82.
3. Douglas SA, Meek TD, Ohlstein EH. Novel receptor antagonists welcome a new era in endothelin biology. Trends Pharmacol Sci 1994;15:313-6.
4. Elliott JD, Lago MA, Peishoff CE. Endothelin receptor antagonists. In: Ruffolo RR Jr. ed. Endothelin receptors: from the gene to the human. Boca Raton, FL: CRC Press; 1995:90-108.
5. Douglas SA, Vickery-Clark LM, Ohlstein EH. Functional evidence that balloon angioplasty results in transient nitric oxide synthase induction. Eur J Pharmacol 1994;255:81-9.
6. Bax WA, Bos E, Saxena PR. Heterogeneity of endothelin/ sarafotoxin receptors mediating contractions of the human isolated saphenous vein. Eur J Pharmacol 1993;239:267-8.
7. White DG, Garratt H, Mundin JW, Sumner MJ, Vallance PJ, Watts IS. Human saphenous vein contains both ETA and ETB contractile receptors. Eur J Pharmacol 1994;257:307-10.
8. Webb ML, Liu EC, Moshizadegan H, et al. Expression of endothelin receptor subtypes in rabbit saphenous vein. Mol Pharmacol 1993;44:959-65.
9. Gray GA, Löffler BM, Clozel M. Characterization of the endothelin receptors mediating contraction of the rabbit saphenous vein. Am J Physiol 1993;266:H959-66.
10. Randall MD, Douglas SA, Hiley CR. Vascular activities of endothelin-1 and some alanyl substituted analogues in resistance beds of the rat. Br J Pharmacol 1989;98:685-99.